Items Tagged ‘personalized immunotherapy’

May 11, 2015

Personalized Immunotherapy Delays Recurrence in Ovarian Cancer


A new immunotherapy known as Vigil™ may help delay the recurrence of advanced ovarian cancer. These findings were presented at the 2015 Annual Meeting on Women’s Cancer, March 28–31, in Chicago, Illinois. According to the American Cancer Society (ACS), ovarian cancer causes more deaths than any other cancer of the female reproductive system. The high […]

View full entry

Tags: News, Ovarian Cancer, personalized immunotherapy, Stage II-IV Ovarian Cancer, vigil